Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Cloudflare Inc (NET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Cloudflare Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while Cloudflare Inc trades at $315.91 (market cap $123.81B). The key difference: Cloudflare Inc is far larger — about 14× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is more actively traded (779,107 versus 1,745,042). Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Cloudflare Inc for 61 Days on average.
| KYMR | NET | |
|---|---|---|
Market Cap | $8.87B | $123.81B |
Volume | 779,107 | 1,745,042 |
Sector | Health | Technology |
52-Week High | $127.31 | $361.00 |
52-Week Low | $55.80 | $160.16 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $8.26B | $123.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Cloudflare (NET) trades at $347.76, down 0.83% on the day but remains near recent highs with strong technical momentum. The company shows impressive revenue growth from $975M in 2022 to $2.17B in 2025, though profitability remains elusive with negative net margins. Recent product launches including Basin data platform and post-quantum certificate authority demonstrate continued innovation, while analyst sentiment remains strongly positive with 71% buy ratings.
While Cloudflare demonstrates robust revenue growth and strategic positioning in cloud security, investors face valuation concerns with P/S of 48.7 and persistent negative profitability. The stock's upside depends on continued enterprise adoption and eventual path to profitability, but high valuation multiples create vulnerability to any growth deceleration. Key risks include competitive pressure and the challenge of converting growth into sustainable earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →
